Proposed Data Collection Submitted for Public Comment and Recommendations, 2517-2518 [2019-01333]
Download as PDF
<![CDATA[
2517
Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices
construction of their state-specific
surveys. Each state administers its
BRFSS questionnaire throughout the
calendar year.
CDC periodically updates the BRFSS
core survey and optional modules. The
purpose of this Revision request is to
add the following topics to the
questionnaires: Myalgic
encephalomyelitis/chronic fatigue
syndrome; hepatitis treatment; adverse
childhood experiences; food stamps;
and opioid use and misuse. In addition,
this request seeks approval for
reinstating topics which have been
included in BRFSS in the past,
dependent upon state interest and
funding. Participation is voluntary and
there is no cost to participate. The total
time burden across all respondents will
be approximately 241,519 hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
U.S. General Population .........................................................
Landline Screener ..................
Cell Phone Screener .............
Field Test Screener ...............
BRFSS Core Survey ..............
BRFSS Optional Modules ......
Field Test Survey ...................
Annual Survey Respondents (Adults >18 Years) ...................
Field Test Respondents (Adults >18 Years) ...........................
Jeffrey M. Zirger,
Acting Lead, Information Collection Review
Office, Office of Scientific Integrity, Office
of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2019–01328 Filed 2–6–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60-Day–19–19LI; Docket No. CDC–2018–
0120]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
ACTION:
Notice with comment period.
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Long-term sequela of Rocky
Mountain spotted fever (RMSF). This
project will look back at hospitalized
cases of RMSF to see if they fully
recovered from their illness, or if they
still experience long-term neurological
effects potentially tied to their RMSF
episode.
SUMMARY:
VerDate Sep<11>2014
17:23 Feb 06, 2019
Jkt 247001
CDC must receive written
comments on or before April 8, 2019.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2018–
0120 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
DATES:
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
375,000
292,682
900
480,000
440,000
500
Average
burden per
response
(in hours)
1
1
1
1
1
1
1/60
1/60
1/60
15/60
15/60
45/60
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Long-term sequela of Rocky Mountain
spotted fever (RMSF)—New ICR—
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Data collection for this investigation
was initiated in July 2018 following
OMB approval on 7/22/2018, with a
second approval on 11/15/2018 under
the Emergency Epidemic Investigations
E:\FR\FM\07FEN1.SGM
07FEN1
2518
Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices
(EEI) Generic ICR (OMB Control
Number 0920–1011, exp 1/31/2020). A
full OMB package is being submitted to
allow for continuation of the project.
Rocky Mountain spotted fever
(RMSF), a life-threatening and rapidly
progressive tickborne disease, is caused
by infection with the bacterium
Rickettsia rickettsii. Infection begins
with non-specific symptoms like fever,
headache, and muscle pain, but when
left untreated the bacteria can cause
damage to blood vessels throughout the
body leading to organ and tissue
damage. Delay in recognition and
treatment of RMSF can result in
irreparable damage leading to
amputation of extremities, neurological
charts, patient interviews, and
neurological exams with a cognitive/
developmental assessment for children.
Resulting data will provide information
to healthcare providers, patients, and
policy makers about the long term
consequences of severe RMSF,
including time to recovery, self-reported
impact to daily function, and will look
to identify risk factors during acute
illness which may be associated with
long term impairment.
There is no cost to respondents other
than the time to participate. Total
estimated burden is 126 hours.
Authorizing Legislation comes from
Section 301 of the Public Health Service
Act (42 U.S.C. 241).
deficits (such as hearing loss, paralysis,
and encephalopathy), and death.
Case series in the peer-reviewed
literature document long term sequelae
(LTS) from RMSF in anywhere from 3–
55% of cases, yet characterization of the
long-term impacts is still not well
understood, and only a handful of
studies have examined them in detail.
Results of neurologic damage caused
during acute RMSF illness may include
symptoms ranging from paresthesia,
insomnia and behavioral concerns to
loss of hearing, motor or language
dysfunction, and chronic pain.
This study will gather information
related to neurologic sequela following
RMSF illness. Information for this study
will come from three sources: Medical
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
(in hours)
Type of respondents
Form name
General Public ...................................
Patient screening questionnaire ......
Neurological exam form ...................
250
125
1
1
10/60
40/60
42
84
Total ...........................................
..........................................................
........................
........................
........................
126
Jeffrey M. Zirger,
Acting Lead, Information Collection Review
Office, Office of Scientific Integrity, Office
of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2019–01333 Filed 2–6–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30-Day–19–18AXG]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Maritime Illness
Database and Reporting System
(MIDRS). CDC previously published a
‘‘Proposed Data Collection Submitted
for Public Comment and
Recommendations’’ notice on
September 25, 2018 to obtain comments
from the public and affected agencies.
CDC did not receive public comment
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
VerDate Sep<11>2014
17:23 Feb 06, 2019
Jkt 247001
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
Maritime Illness Database and
Reporting System (MIDRS)—NEW—
National Center for Environmental
Health (NCEH), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The purpose of this new information
collection request (ICR) is to request a
three-year Paperwork Reduction Act
(PRA) clearance for CDC’s Maritime
Illness Database and Reporting System
(MIDRS). MIDRS is currently approved
under Foreign Quarantine Regulations
(42 CFR part 71) (OMB Control No.
0920–0134, Expiration Date: 05/31/
2019), sponsored by the National Center
for Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Operationally, CDC has divided the
responsibilities for enforcing foreign
quarantine regulations between the
Vessel Sanitation Program (VSP) and the
Division of Global Migration and
Quarantine (DGMQ). VSP takes the lead
on overseeing acute gastroenteritis
(AGE) illness surveillance and outbreak
investigation activities on passenger
E:\FR\FM\07FEN1.SGM
07FEN1
]]>Agencies
[Federal Register Volume 84, Number 26 (Thursday, February 7, 2019)]
[Notices]
[Pages 2517-2518]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01333]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60-Day-19-19LI; Docket No. CDC-2018-0120]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Long-term sequela of Rocky
Mountain spotted fever (RMSF). This project will look back at
hospitalized cases of RMSF to see if they fully recovered from their
illness, or if they still experience long-term neurological effects
potentially tied to their RMSF episode.
DATES: CDC must receive written comments on or before April 8, 2019.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2018-
0120 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
Long-term sequela of Rocky Mountain spotted fever (RMSF)--New ICR--
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID),
Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Data collection for this investigation was initiated in July 2018
following OMB approval on 7/22/2018, with a second approval on 11/15/
2018 under the Emergency Epidemic Investigations
[[Page 2518]]
(EEI) Generic ICR (OMB Control Number 0920-1011, exp 1/31/2020). A full
OMB package is being submitted to allow for continuation of the
project.
Rocky Mountain spotted fever (RMSF), a life-threatening and rapidly
progressive tickborne disease, is caused by infection with the
bacterium Rickettsia rickettsii. Infection begins with non-specific
symptoms like fever, headache, and muscle pain, but when left untreated
the bacteria can cause damage to blood vessels throughout the body
leading to organ and tissue damage. Delay in recognition and treatment
of RMSF can result in irreparable damage leading to amputation of
extremities, neurological deficits (such as hearing loss, paralysis,
and encephalopathy), and death.
Case series in the peer-reviewed literature document long term
sequelae (LTS) from RMSF in anywhere from 3-55% of cases, yet
characterization of the long-term impacts is still not well understood,
and only a handful of studies have examined them in detail. Results of
neurologic damage caused during acute RMSF illness may include symptoms
ranging from paresthesia, insomnia and behavioral concerns to loss of
hearing, motor or language dysfunction, and chronic pain.
This study will gather information related to neurologic sequela
following RMSF illness. Information for this study will come from three
sources: Medical charts, patient interviews, and neurological exams
with a cognitive/developmental assessment for children. Resulting data
will provide information to healthcare providers, patients, and policy
makers about the long term consequences of severe RMSF, including time
to recovery, self-reported impact to daily function, and will look to
identify risk factors during acute illness which may be associated with
long term impairment.
There is no cost to respondents other than the time to participate.
Total estimated burden is 126 hours. Authorizing Legislation comes from
Section 301 of the Public Health Service Act (42 U.S.C. 241).
Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
--------------------------------------------------------------------------------------------------------------------------------------------------------
General Public................................. Patient screening questionnaire........ 250 1 10/60 42
Neurological exam form................. 125 1 40/60 84
---------------------------------------------------------------
Total...................................... ....................................... .............. .............. .............. 126
--------------------------------------------------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Acting Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2019-01333 Filed 2-6-19; 8:45 am]
BILLING CODE 4163-18-P
